Cargando…

Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma

BACKGROUND: The MexTAg transgenic mouse model of mesothelioma replicates many aspects of human mesothelioma, including induction by asbestos, pathogenicity and response to cytotoxic chemotherapy, despite high levels of the SV40 large T Antigen (TAg) in the mesothelial compartment. This model enables...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Cleo, Dick, Ian M., Wise, Michael J., Holloway, Andrew, Diyagama, Dileepa, Robinson, Bruce W. S., Creaney, Jenette, Lake, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683914/ https://www.ncbi.nlm.nih.gov/pubmed/26680231 http://dx.doi.org/10.1186/s12885-015-1953-y

Ejemplares similares

Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015)

How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies
por: Robinson, Bruce W.S., et al.
Publicado: (2022)

Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2017)

Auto-Antibodies to β-F1-ATPase and Vimentin in Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2011)

ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
por: Morré, D. James, et al.
Publicado: (2016)

Statins Do Not Alter the Incidence of Mesothelioma in Asbestos Exposed Mice or Humans
por: Robinson, Cleo, et al.
Publicado: (2014)

Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
por: Morré, D. James, et al.
Publicado: (2016)

Association of Biomarker Levels with Severity of Asbestos-Related Diseases
por: Park, Eun-Kee, et al.
Publicado: (2012)

Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma
por: Fan, Xiyong, et al.
Publicado: (2019)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo
por: Greening, David W., et al.
Publicado: (2016)

Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
por: Creaney, Jenette, et al.
Publicado: (2013)

Chrysotile Asbestos and Mesothelioma
por: Lemen, Richard A.
Publicado: (2010)

Hyaluronic acid in viscous malignant mesothelioma pleural effusion
por: Cheah, Hui Min, et al.
Publicado: (2020)

What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
por: Redwood, Alec J., et al.
Publicado: (2022)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Asbestos and Mesothelioma: A Comment
por: Jargin, Sergei V.
Publicado: (2018)

Absence of calretinin protein expression in malignant mesotheliomas from asbestos-exposed NF2(+/−) mice and mouse mesothelioma cell lines from various mouse strains
por: Blum, Walter, et al.
Publicado: (2018)

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
por: Chee, Jonathan, et al.
Publicado: (2018)

Calretinin as a blood-based biomarker for mesothelioma
por: Johnen, Georg, et al.
Publicado: (2017)

Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2019)

Statistical analysis of an RNA titration series evaluates microarray precision and sensitivity on a whole-array basis
por: Holloway, Andrew J, et al.
Publicado: (2006)

Profile of soluble factors in pleural effusions predict prognosis in mesothelioma
por: Dick, I.M., et al.
Publicado: (2022)

Mesotheliomas in rats following inoculation with asbestos.
por: Wagner, J. C., et al.
Publicado: (1969)

Thymectomy and asbestos-induced mesotheliomas in rats.
por: Wagner, M. M.
Publicado: (1979)

Asbestos, mesothelioma and the legacy of shipbuilding in Belfast
por: Morrison, Patrick J
Publicado: (2008)

Asbestos Exposure and the Mesothelioma Incidence in Poland
por: Krówczyńska, Małgorzata, et al.
Publicado: (2018)

Software for Apportionment of Asbestos-Related Mesotheliomas
por: Ross, Robert M.
Publicado: (2016)

Immune marker expression of irradiated mesothelioma cell lines
por: Chang, Faith, et al.
Publicado: (2022)

p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression
por: Creaney, J, et al.
Publicado: (2001)

Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma
por: Meniawy, T M, et al.
Publicado: (2013)

Treatments affecting the rate of asbestos-induced mesotheliomas.
por: Wagner, J. C., et al.
Publicado: (1980)

Asbestos Burden Predicts Survival in Pleural Mesothelioma
por: Christensen, Brock C., et al.
Publicado: (2008)

Where There Is Asbestos, There Is Mesothelioma: Filling in the Data Blanks
por: Haynes, Rebecca Clay
Publicado: (2011)

Susceptibility and resistance in the genesis of asbestos-related mesothelioma
por: Bianchi, Claudio, et al.
Publicado: (2008)

Malignant Mesothelioma after Household Exposure to Asbestos
por: Saba, Raya, et al.
Publicado: (2013)

Malignant Peritoneal Mesothelioma Without Asbestos Exposure
por: Abbas, Hafsa, et al.
Publicado: (2019)

How asbestos and other fibers cause mesothelioma
por: Gaudino, Giovanni, et al.
Publicado: (2020)

Response to comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'
por: Meniawy, T M, et al.
Publicado: (2014)

Asbestos-induced peritoneal mesothelioma in a construction worker.
por: Fonte, Rodolfo, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_9dn8e3nkfjgocopbh9tcnabjkb